Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1296

1.

Seasonal variations in vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment.

Andersson B, Swolin-Eide D, Kriström B, Gelander L, Magnusson P, Albertsson-Wikland K.

J Endocrinol Invest. 2015 Aug 9. [Epub ahead of print]

PMID:
26253710
2.

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Lee HC, Saliba RM, Rondon G, Chen J, Charafeddine Y, Medeiros LJ, Alatrash G, Andersson BS, Popat U, Kebriaei P, Ciurea S, Oran B, Shpall E, Champlin R.

Biol Blood Marrow Transplant. 2015 Jul 14. pii: S1083-8791(15)00461-9. doi: 10.1016/j.bbmt.2015.07.005. [Epub ahead of print]

PMID:
26183077
3.

Chromosomal copy number variation reveals differential levels of genomic plasticity in distinct Trypanosoma cruzi strains.

Reis-Cunha JL, Rodrigues-Luiz GF, Valdivia HO, Baptista RP, Mendes TA, de Morais GL, Guedes R, Macedo AM, Bern C, Gilman RH, Lopez CT, Andersson B, Vasconcelos AT, Bartholomeu DC.

BMC Genomics. 2015 Jul 4;16:499. doi: 10.1186/s12864-015-1680-4.

4.

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.

Ansari D, Lund LH, Stehlik J, Andersson B, Höglund P, Edwards L, Nilsson J.

J Heart Lung Transplant. 2015 May 2. pii: S1053-2498(15)01204-8. doi: 10.1016/j.healun.2015.04.001. [Epub ahead of print]

PMID:
26087667
5.

Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.

Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, Oki Y, Hagemeister F, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS.

Biol Blood Marrow Transplant. 2015 Jun 11. pii: S1083-8791(15)00405-X. doi: 10.1016/j.bbmt.2015.06.003. [Epub ahead of print]

PMID:
26071868
6.

Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Lüscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE.

Eur Heart J. 2015 May 18. pii: ehv192. [Epub ahead of print] Review. No abstract available.

PMID:
25990344
7.

Genetic variation at the human connexin 43 locus but not at the connexin 40 locus is associated with left bundle branch block.

Ladenvall P, Andersson B, Dellborg M, Hansson PO, Eriksson H, Thelle D, Eriksson P.

Open Heart. 2015 Apr 10;2(1):e000187. doi: 10.1136/openhrt-2014-000187. eCollection 2015.

8.

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Oran B, Jimenez AM, De Lima M, Popat UR, Bassett R, Andersson BS, Borthakur G, Bashir Q, Chen J, Ciurea SO, Jabbour E, Cortes J, Kebriaei P, Khouri IF, Qazilbash MH, Ravandi F, Rondon G, Lu X, Shpall EJ, Champlin RE.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1405-12. doi: 10.1016/j.bbmt.2015.03.023. Epub 2015 Mar 31.

PMID:
25840338
9.

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.

Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators.

Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214. Epub 2015 Mar 17.

PMID:
25783974
10.

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.

Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, Yvon E, de Lima M, Cooper LJ, Tewari P, Champlin RE, Nieto Y, Andersson BS, Alousi A, Jones RB, Qazilbash MH, Bashir Q, Ciurea S, Ahmed S, Anderlini P, Bosque D, Bollard C, Molldrem JJ, Chen J, Rondon G, Thomas M, Miller L, Wolpe S, Simmons P, Robinson S, Zweidler-McKay PA, Shpall EJ.

Blood. 2015 May 7;125(19):2885-92. doi: 10.1182/blood-2015-01-607366. Epub 2015 Mar 16.

PMID:
25778529
11.

The International Heart Transplant Survival Algorithm (IHTSA): a new model to improve organ sharing and survival.

Nilsson J, Ohlsson M, Höglund P, Ekmehag B, Koul B, Andersson B.

PLoS One. 2015 Mar 11;10(3):e0118644. doi: 10.1371/journal.pone.0118644. eCollection 2015.

12.

Outcomes after ABO-incompatible heart transplantation in adults: A registry study.

Bergenfeldt H, Andersson B, Bućin D, Stehlik J, Edwards L, Rådegran G, Nilsson J.

J Heart Lung Transplant. 2015 Jul;34(7):892-8. doi: 10.1016/j.healun.2015.01.008. Epub 2015 Jan 16.

PMID:
25754241
13.

Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.

Valdez BC, Li Y, Murray D, Ji J, Liu Y, Popat U, Champlin RE, Andersson BS.

Exp Hematol. 2015 Jun;43(6):448-61.e2. doi: 10.1016/j.exphem.2015.02.001. Epub 2015 Feb 19.

PMID:
25704054
14.

Fast-track program for liver resection--factors prolonging length of stay.

Blind PJ, Andersson B, Tingstedt B, Bergenfeldt M, Andersson R, Lindell G, Sturesson C.

Hepatogastroenterology. 2014 Nov-Dec;61(136):2340-4.

PMID:
25699379
15.

[Cerebral hemorrhage after ingestion of the performance enhancer "Jacked Power". Healthy woman fell ill during exercise after a single dose].

Zeijlon R, Andersson B.

Lakartidningen. 2014 Oct 8-14;111(41):1782-4. Swedish. No abstract available.

PMID:
25699325
16.

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

Alousi AM, Brammer JE, Saliba RM, Andersson B, Popat U, Hosing C, Jones R, Shpall EJ, Khouri I, Qazilbash M, Nieto Y, Shah N, Ahmed S, Oran B, Al Atrash G, Ciurea S, Kebriaei P, Chen J, Rondon G, Champlin RE.

Biol Blood Marrow Transplant. 2015 May;21(5):906-12. doi: 10.1016/j.bbmt.2015.01.026. Epub 2015 Feb 7.

PMID:
25667989
17.

Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment.

Burda P, Kuster A, Hjalmarson O, Suormala T, Bürer C, Lutz S, Roussey G, Christa L, Asin-Cayuela J, Kollberg G, Andersson BA, Watkins D, Rosenblatt DS, Fowler B, Holme E, Froese DS, Baumgartner MR.

J Inherit Metab Dis. 2015 Jan 30. [Epub ahead of print]

PMID:
25633902
18.

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure MAGGIC.

Eur Heart J. 2015 May 7;36(18):1106-14. doi: 10.1093/eurheartj/ehu490. Epub 2015 Jan 23.

PMID:
25616644
19.

ABO-identical blood group matching has no survival benefit for AB heart transplant recipients.

Bergenfeldt H, Höglund P, Andersson B, Rådegran G, Ohlsson M, Nilsson J.

Ann Thorac Surg. 2015 Mar;99(3):762-8. doi: 10.1016/j.athoracsur.2014.10.031. Epub 2015 Jan 15.

PMID:
25597790
20.

Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials.

Feldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, Stepinska J, Zembala M, Rouleau J, Velazquez EJ, Lee KL.

Cardiology. 2015;130(2):69-81. doi: 10.1159/000368221. Epub 2015 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk